**What was known?**

The authors have recently demonstrated a simple but novel way of detection of *M. leprae* in the affected nerves of pure neural leprosy patients by combining FNAC and PCRPNL remains localized to one or few nerves for years escaping the host immunityMany obligate intracellular bacteria showed evidence of genomic reduction

Introduction {#sec1-1}
============

Unlike other mycobacteria, *Mycobacterium leprae* is unique in the fact that it is an obligate intracellular parasite and serves as excellent model to study how these bacteria exploit the functions of their host cells. Obligatory intracellular parasites possess a small genome and have a tendency for genomic reduction. Genome reduction is a common phenomenon of these obligatory intracellular parasites that target overlapping subsets of potentially dispensable genes while adapting to the selective pressure of different niches.\[[@ref1]\] However, the deletion of genes in pathogens may also have a detrimental effect on their fitness and on their ability to cause disease.\[[@ref2]\]

TTC repeat is a variable number of tandem repeat stable and specific for a strain of *M. leprae*. This has been found to be 21 in cases of non-mutant strains.\[[@ref2]\] Also, two folP homologs folP1 and folP2 have been found to be important to the bacterial susceptibility to the treatment.\[[@ref3]\]

In case of Pure Neural Hansen (PNL), *M. leprae* is restricted to the peripheral nerves. Recently, the authors have described a simple but objective method of diagnosis of PNL by using fine needle aspiration and multiplex PCR.\[[@ref4]\] However, we perceive that there is a considerable lack of data regarding the genomic changes in *M. leprae* which confines itself to a low grade infection of peripheral nerves for years. We postulate that this adaptation to this intra-cellular niche may be accompanied by either gene loss or mutation in susceptibility genes.

In this study we attempted to find if there is a consistent pattern of gene loss at TTC tandem repeats or susceptibility mutation in either folP or rpoB genes which may be the reason for the restriction and survival of *M. leprae* in the nerves of the host.

Materials and Methods {#sec1-2}
=====================

 {#sec2-1}

### Patients' selection criteria {#sec3-1}

All clinically suspected cases of PNL were subjected to fine-needle aspiration (FNA) from the affected nerves after duly signing an informed consent form. Aspirates were subjected to DNA extraction and multiplex PCR for detection of *M. leprae*. PNL cases with a confirmed microbiological diagnosis by multiplex cases were only included for further study of genomic reduction and susceptibility mutation.

### Fine-needle aspiration {#sec3-2}

FNA was done as described by Theuvenet *et al.*\[[@ref5][@ref6]\] We used a 10 ml syringe with 23-G needle for FNA cytology (FNAC). Most commonly ulnar nerve was taken for FNAC due to its easy approachability. Small amount of normal saline was first injected into the nerve for easier tapping. Aspirates were then subjected to cytology (hematoxylin and eosin), special staining with Ziehl-Neelsen and DNA extraction.

### Extraction of DNA from the FNAC samples {#sec3-3}

Genomic DNA was extracted from a portion of the fine-needle aspirates, collected aseptically with the standard precautions by the standard Phenol Chloroform method after proteinase-K digestion as described by Banerjee *et al.*\[[@ref7]\]

### PCR amplification of TTC repeats {#sec3-4}

The primer used for region flanking entire 21TTC repeat sequences was originally designed by Shin *et al.*\[[@ref2]\] A non-mutant Thai 53 strain was used as a negative control, which was previously used by other workers.\[[@ref8]\] Both the primers were designed based on the *M. leprae* genome sequences flanking the TTC repeats to make sure that only the *M. leprae* genomic DNA would anneal with the primers \[[Table 1](#T1){ref-type="table"}\].

###### 

The detailed primer sequence and Tm values for PCR based molecular diagnosis and detection of mutations for Rifampicin and Dapsone

![](IJD-60-351-g001)

### Detection of mutations in the folp1 gene {#sec3-5}

The molecualar detection of mutation in the folp1 gene of *M. leprae* was done as explained by Williams and Gillis.\[[@ref3]\] Briefly this assay required PCR Amplification of SRDR (Sulphone Resistance Determining Region) of the folP1 by the primers explained in [Table 1](#T1){ref-type="table"} and mixing of these PCR products with a universal heteroduplex generator (UHG - DDS - 441). The SRDR PCR products were further analyzed for single-stranded conformational polymorphism as explained by Bannerjee *et al.*\[[@ref7]\]

### Detection of mutation in the rpoB gene {#sec3-6}

Molecular detection in the rpoB gene of *M. leprae* was determined. Multiple primer PCR Amplification Refractory mutation System (MARS) assay was done as explained by Sapkota *et al.*\[[@ref8]\] Briefly, eliquotes of FNA homogenate were subjected to five cold and heat shocks, achieved by snap freezing in liquid nitrogen for 1 min followed by boiling at 100 C in a dry heat block. The crude lysate was used as template in PCR amplification by using the primers explained in [Table 1](#T1){ref-type="table"}.

### PCR conditions {#sec3-7}

Approximately 100 ng genomic DNA was amplified with Ampli *Taq* Gold (Applied Biosystems, Inc. \[ABI\], Foster City, CA) in a PCR reaction mixtures, containing 1x PCR buffer (Applied Biosystems), 2 mM MgCl~2~, 0.25 mM each dNTP, 20 picomoles primers TTC-A and TTC-B, folP1F and folP1R, CFP, CRP and M425. The primer sequences, primer annealing temperature (Ta°), and PCR product sizes are given in [Table 1](#T1){ref-type="table"}. The PCR reactions were performed under the following conditions: 95°C for 4 minutes, followed by 35 cycles of 95°C for 1 min, Ta° for the internal control as in [Table 1](#T1){ref-type="table"} for 1 min, 72°C for 1 min, and then 72°C for 10 minutes for the final extension. The amplified products were separated by electrophoresis on 2% agarose gel stained with 0.5 mg/mL ethidium bromide and visualized and photographed under a UV transilluminator.

Results {#sec1-3}
=======

A total of 33 cases were subjected to fine needle aspiration of which 24 cases were found to be positive for *M. leprae* in multiplex PCR as in [Table 2](#T2){ref-type="table"}. These cases were included in this study and their aspirates were subjected to genome reduction analysis at TTC tandem repeats and susceptibility mutation analysis for the genes folP and rpoB.

###### 

Detailed mutation study for TTC, rpoB and folP regions of *M. leprae*

![](IJD-60-351-g002)

Out of the 24 cases 23 cases were males and 1 patient was female as shown in [Table 2](#T2){ref-type="table"}. In multiplex PCR study, all 24 cases were found positive for the presence of *M. leprae* DNA. The mutation study was done by amplifying the concerned gene by PCR and \[[Figure 1](#F1){ref-type="fig"}\] further subjecting to DNA sequencing as shown in Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}. The obtained data was analyzed by NCBI Basic Local Alignment Search Tool (NCBI BLAST). On analysis of mutation pattern 15 out of 24 positive patients showed a loss of 5bp in the nucleotide sequence of TTC repeats as in [Figure 4](#F4){ref-type="fig"}, while the other 9 patients showed 3bp loss in the nucleotide sequence as shown in Figures [5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}. Moreover, the mutation analysis for folP1 did not show any mutation in bacterium genome in any of the patients as in [Table 2](#T2){ref-type="table"} while 1 out of 24 patients showed to have a few point mutations in the rpoB gene of the bacterium as shown in [Figure 3](#F3){ref-type="fig"}.

![PCR product on electrophoresis in 2% agarose gel. Lane 1: X174 marker. Lane 2: Patient sample. Lane 3: Patient sample. Lane 4: Patient sample. Lane 5: Patient sample. Lane 6: Negative control (Thai 53.) Lane 2, 3, 4 and 5 showed a clear shift in TTC repeat](IJD-60-351-g003){#F1}

![Dendogram representing the rpoB gene sequence of M. leprae](IJD-60-351-g004){#F2}

![NCBI BLAST analysis result for the rpoB gene (Circles shows mutation sites)](IJD-60-351-g005){#F3}

![Dendogram representing the TTC repeat sequence of M. leprae](IJD-60-351-g006){#F4}

![NCBI BLAST analysis result for TTC repeats. Circle shows lost in 3 base pairs](IJD-60-351-g007){#F5}

![NCBI BLAST analysis result for TTC repeats. Circle shows lost in 5 base pairs](IJD-60-351-g008){#F6}

Discussion {#sec1-4}
==========

Although neural leprosy cases were not extensively studied for the genetic and biochemical changes in the bacilli, it provokes questions regarding the unusual ability and tendency of the bacilli to proliferate inside neural tissue surviving the host defense. Many obligate inter-cellular bacteria have been found to show the phenomenon of genomic reduction which supposedly help them to adapt their particular intercellular niche.\[[@ref9]\] We tried to find out, in these unusual subset of leprosy, if there is any changes in the bacterial genome either in the form of genomic reduction or in the form susceptibility gene mutation.

We found the rate of mutation in the mycobacterium leprae genome obtained from the fine-needle aspirate of the pure neural Hansen cases is considerably higher in the variable number tandem repeats like TTC repeats. We observed a loss of 5 base pairs in 15 cases as in [Figure 4](#F4){ref-type="fig"} and loss of 3 base pair in 9 cases as shown in [Figure 4](#F4){ref-type="fig"}. TTC repeat is the number of tandem repeats in *M. leprae*, reported first by Shin *et al.* as shown in [Figure 3](#F3){ref-type="fig"}. It had been reported that non-mutant strain of *M. leprae* has 21 repeats.\[[@ref2]\] The stability of this TTC repeat was studied and reported by Masanori Matsuoaka *et al.* in 2004 and was found that the copy number of the TTC repeats in each laboratory maintained isolates remain stable even after several serial passages in the nude mice footpads.\[[@ref10]\] Our findings thus show that there is definitely some amount of genomic reduction in the bacilli affecting and restricting itself to nerves.

Also, as earlier reports by Sapkota *et al.* and Williams *et al.* suggest, some point mutations in the folp1 gene and rpoB gene may cause the change in metabolic activities of the bacterium; hence, we studied the mutation pattern in these genes.\[[@ref3][@ref11]\]

Genome sequencing of *M. leprae* revealed that it possesses two folP homologs (folP1 and folP2). Among these two homologues folP1 appears to be part of an operon containing three other genes involved in folate biosynthesis which is similar to that of *M. tuberculosis*.\[[@ref3]\] Williams *et al.* showed that mutation in this gene contributes to change in susceptibility of the bacterium to drugs.\[[@ref3]\] Sapkota *et al.* showed the mutation in other short, highly conserved region called rifampicin resistance determining region (RRDR) of the rpoB gene effecting codon 401-427 may also contribute to susceptibility of the bacterium to drugs.\[[@ref12]\]

We found that none of these cases had any mutation in the folP1 gene of the bacterium ruling out any possibilities of resistance against Dapson. Also, the study for the mutation in the rpoB gene showed point mutations in the rpoB gene of only one patient as shown in [Figure 2](#F2){ref-type="fig"}. Thus, of the 24 cases only 1 case may have primary resistance against Rifampicin.

Matsuoaka *et al.* suggested that changes in TTC may result in strain difference.\[[@ref10]\] However, it remained unclear how this change affect bacterial susceptibility and pathogenecity. Since, 23 of our 24 cases did not have any susceptibility gene mutation but all of our cases showed definite sign of genomic reduction; it raises the question if genomic reduction at TTC repeat could be the cause of this unique restriction of the bacilli in the neural tissue in the cases of pure neural Hansen disease. However, further studies with larger number of cases and with studies of detailed biochemical changes may give us further clues to understand the survival strategies of the bacteria.

Conclusion {#sec1-5}
==========

All cases of pure neural leprosy showed consistent genomic reduction at the TTC base pair tandem repeats which could well be the cause of this unique clinical restriction to neural tissue of this subset of leprosy.

**What is new?**

All cases of pure neural leprosy showed consistent genomic reduction at the TTC base pair repeatsmThis can be the cause of unique clinical restriction to neural tissue of this subset of leprosyThis can also be a part of the survival strategy of the bacilli to survive difficult host niche.
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